Quarry LP Takes Position in Cellebrite DI Ltd. (NASDAQ:CLBT)

Quarry LP bought a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,603 shares of the company’s stock, valued at approximately $27,000.

Several other institutional investors also recently added to or reduced their stakes in CLBT. FMR LLC increased its position in Cellebrite DI by 136.3% in the 3rd quarter. FMR LLC now owns 5,616,757 shares of the company’s stock valued at $94,586,000 after acquiring an additional 3,239,307 shares during the period. Meitav Investment House Ltd. grew its holdings in Cellebrite DI by 29.7% in the third quarter. Meitav Investment House Ltd. now owns 2,066,322 shares of the company’s stock valued at $34,797,000 after purchasing an additional 473,293 shares during the last quarter. Pembroke Management LTD increased its holdings in Cellebrite DI by 24.3% during the 3rd quarter. Pembroke Management LTD now owns 1,908,345 shares of the company’s stock valued at $32,137,000 after acquiring an additional 372,619 shares in the last quarter. Principal Financial Group Inc. acquired a new position in Cellebrite DI during the third quarter worth about $23,402,000. Finally, Portolan Capital Management LLC lifted its holdings in shares of Cellebrite DI by 19.9% in the third quarter. Portolan Capital Management LLC now owns 1,224,020 shares of the company’s stock valued at $20,612,000 after purchasing an additional 203,068 shares in the last quarter. Institutional investors and hedge funds own 45.88% of the company’s stock.

Cellebrite DI Price Performance

CLBT opened at $20.04 on Friday. The stock has a market cap of $4.13 billion, a P/E ratio of -12.93, a P/E/G ratio of 2.91 and a beta of 1.51. Cellebrite DI Ltd. has a 12 month low of $7.91 and a 12 month high of $21.72. The stock’s 50 day moving average price is $18.88 and its 200 day moving average price is $15.69.

Cellebrite DI (NASDAQ:CLBT) last announced its earnings results on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.09 by $0.05. The firm had revenue of $106.90 million for the quarter, compared to analysts’ expectations of $102.06 million. Cellebrite DI had a positive return on equity of 122.59% and a negative net margin of 82.28%. The firm’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.09 earnings per share. Equities analysts anticipate that Cellebrite DI Ltd. will post 0.32 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on CLBT. Bank of America raised their target price on shares of Cellebrite DI from $13.00 to $17.00 and gave the stock a “buy” rating in a research report on Friday, August 16th. JPMorgan Chase & Co. increased their price objective on shares of Cellebrite DI from $21.00 to $22.00 and gave the stock an “overweight” rating in a research report on Thursday, November 7th. TD Cowen raised their target price on Cellebrite DI from $20.00 to $23.00 and gave the company a “buy” rating in a report on Monday, September 23rd. Lake Street Capital upped their price objective on shares of Cellebrite DI from $13.50 to $17.00 and gave the company a “buy” rating in a research report on Friday, August 16th. Finally, Needham & Company LLC raised their price target on shares of Cellebrite DI from $17.00 to $21.00 and gave the stock a “buy” rating in a research report on Thursday, November 7th. Eight investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Cellebrite DI currently has an average rating of “Buy” and an average price target of $20.29.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.